Simson Pharma
Simson Pharma Limited is an Indian specialty manufacturer of pharmaceutical reference standards, impurity standards, stable isotope-labelled compounds, metabolites, and custom-synthesized organic molecules, supplying pharmaceutical manufacturers, research institutions, and QC laboratories in domestic and international markets.
- Company typePrivate
- Founded2011
- HeadquartersMumbai, India
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Simson Pharma does
Simson Pharma Limited is an Indian specialty manufacturer of pharmaceutical reference materials, founded in 2011 and headquartered in Mumbai with an R&D and production campus in Hyderabad. The company produces certified reference standards, working standards, impurity standards (including nitrosamine and peptide impurities), stable isotope-labelled compounds, drug metabolites, and research chemicals, alongside custom synthesis services that produce complex organic molecules at milligram to kilogram scale. Operations are anchored by a Ph.D.-level synthetic chemistry team and an in-house analytical testing laboratory equipped with HPLC, GC, GC-HS, FTIR, LCMS, ICPMS, CHNSO, TGA, PSD, and dissolution apparatus for full quality control and characterization.
The business operates on a B2B direct sales model with separate India-domestic and international-export channels, a dedicated CRO/bio-analytics channel, and a dedicated UK subsidiary (SimSon Pharma Global Ltd.) targeting European and global regulated markets. Pricing is quote-based and not publicly disclosed; the company supplies Certificates of Analysis (COA) and sample technical data for buyer evaluation. Customer segments are described as horizontal: pharmaceutical manufacturers, academic and research institutions, and independent quality control laboratories.
Revenue mechanics are weighted toward one-time catalog sales of standards and impurity references, supplemented by professional-services revenue from custom synthesis engagements. The company holds a dense regulatory credential stack (ISO 9001, ISO 14001, ISO 45001, ISO 17034, ISO 17025, NABL, GMP, DSIR), which functions as the primary gatekeeper for entry into regulated pharmaceutical QC supply chains. Group structure comprises the parent entity plus wholly-owned subsidiaries SimSon Chemtech, SimSon Chemie, and SimSon Pharma Services, with no disclosed external venture or private equity backing.
Simson Pharma firmographics
Firmographics- Name
- Simson Pharma
- Legal name
- Simson Pharma Limited
- Website
- https://simsonpharma.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Simson Pharma Limited is an Indian specialty manufacturer of pharmaceutical reference standards, impurity standards, stable isotope-labelled compounds, metabolites, and custom-synthesized organic molecules, supplying pharmaceutical manufacturers, research institutions, and QC laboratories in domestic and international markets.
- Ownership category
- akta.pro rank
Where Simson Pharma is headquartered
LocationHeadquarters
- HQ city
- Mumbai
- HQ country
- India
- HQ region
- Asia
Offices2 records
Markets served
Simson Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Pharmaceutical Reference Standards: Sale of pharmaceutical reference standards used for quality control and analytical testing in pharmaceutical manufacturing and research.
- Impurity Standards: Sale of pharmaceutical impurity standards essential for analytical testing, quality control, and regulatory compliance in drug development and manufacturing.
- Custom Synthesis Services: Custom synthesis of complex organic molecules in mg to Kg scale for specific customer requirements, including novel compounds and known molecules.
- Isotope Labelled Compounds: Stable isotope labelled compounds for research and analytical applications, enabling tracing of compounds through physical, chemical, or biological processes.
- Research Chemicals: Research chemicals produced by custom synthesis methods for laboratory research use only.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
Simson Pharma product offering
Product offeringCore offering
Simson Pharma manufactures and supplies pharmaceutical reference materials used in drug quality control and analytical testing, including reference standards, working standards, impurity standards, stable isotope labelled compounds, drug metabolites, and research chemicals. The company operates custom synthesis services that produce complex organic molecules from milligram to kilogram scale, supported by in-house analytical testing and quality assurance laboratories located in Hyderabad, India.
Product overview
Simson Pharma is a quality-driven pharmaceutical solutions company offering a comprehensive portfolio of reference standards, impurity standards, research chemicals, and custom synthesis services for the pharmaceutical industry. The core product portfolio consists of Reference Standards, Working Standards, Impurity Standards, Isotope Labelled Compounds, Metabolites, and Research Chemicals, all used for pharmaceutical development, quality control testing, and regulatory compliance. The company also provides Custom Synthesized Compounds as an add-on service enabling production of complex organic molecules from milligram to kilogram scale. Specialized product sub-categories include Nitrosamine Impurities, Complex Impurity Products, Labelled Reagent Products, Stable Isotope Labelled Compounds, Peptide Impurity products, Complex Isotope Labelled & Metabolites, and Controlled Substance products. The company operates R&D laboratories in Hyderabad, India, featuring Custom Synthesis, Analytical Testing, Formulations Research, Microbiological, and Quality Assurance facilities.
Differentiator
Problem solved
Functional benefit
Products and services
- Reference Standards Pharmaceutical reference standards used as benchmarks for quality control and regulatory compliance testing in drug manufacturing and research, supplied to pharmaceutical manufacturers, CROs, and research laboratories.
- Working Standards Drug substance or chemical material of established quality and purity, used as a reference working substance for routine quality control analysis in pharmaceutical labs.
- Impurity Standards Pharmaceutical impurity standards used for quality control and safety testing, ensuring drug purity and regulatory compliance for pharmaceutical manufacturers and testing labs.
- Isotope Labelled Compounds Chemical substances in which part of the molecules are labelled with an isotope, used to trace the compound or its fragments through physical, chemical, or biological processes in pharmaceutical and research applications.
- Metabolites Intermediate end products of metabolism, including drug metabolites which are byproducts of drug breakdown used in pharmaceutical research, quality control, and bioanalytics.
- Research Chemicals Chemical substances used by scientists for scientific research and development purposes, produced by custom synthesis methods and intended for laboratory research use only (not for human or veterinary use).
- Custom Synthesized Compounds Custom synthesis services delivering complex organic molecules in milligram to kilogram scale, with experienced Ph.D. scientists designing synthetic routes for both new and known compounds for pharma and research customers.
Companies that use Simson Pharma
Customer profileSegments3 records
Ideal customer profiles3 records
Simson Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Simson Pharma partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights4 records
Simson Pharma competitors and assessment
Company assessmentEmerging players
- Clearsynth: India-based specialist in stable isotope-labelled compounds and reference standards, with comparable custom synthesis capabilities. Direct emerging competitor to Simson, particularly in isotope-labelled compounds and complex impurities.
- Selleck Chemicals: Specializes in inhibitor libraries, reference compounds, and impurity standards for pharmaceutical R&D. Comparable to Simson's research chemicals and impurity standards segments, serving a partially overlapping pharma R&D customer base.
- Cayman Chemical: Specialty manufacturer of analytical reference standards, metabolites, and biochemical research reagents. Overlaps with Simson on metabolite and impurity standards, serving pharma QC and academic research customers.
Direct peers
- LGC Standards: European-based reference materials producer with ISO 17034 accreditation offering pharmaceutical impurity, reference, and isotope-labelled standards. Directly comparable to Simson in accreditation profile, product mix, and target customers.
- Toronto Research Chemicals (TRC): Specialist manufacturer of impurity standards, reference standards, metabolites, and stable isotope-labelled compounds. Closely aligned with Simson's product mix and serving pharma R&D and QC customers globally.
- United States Pharmacopeia (USP): Pharmacopoeial reference standards body producing the most widely used compendial reference standards globally. Directly comparable as a pharma reference standards supplier to Simson's reference standards and working standards lines.
- TCI Chemicals: Manufacturer and global supplier of research chemicals, reference standards, and custom synthesis services with strong catalogue presence. Comparable to Simson's research chemicals and custom synthesis offerings.
- Santa Cruz Biotechnology: Supplier of research chemicals, antibodies, and reference standards for life science research. Comparable to Simson on research chemicals and reference standards, particularly in academic and research institution customer segments.
- Merck KGaA (Sigma-Aldrich): Operates the world's largest pharmaceutical reference standards and impurity standards catalogue via the Sigma-Aldrich brand. Directly comparable to Simson across reference standards, impurity standards, and isotope-labelled compounds, with overlapping pharma QC customer base.
Broad incumbents
- Thermo Fisher Scientific: Major life sciences tools incumbent offering reference materials, custom synthesis, and analytical testing services through its Chemicals & Manufacturing Solutions segment. Competes with Simson on reference standards and custom synthesis as part of a much broader portfolio.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Simson Pharma social profiles
Digital presenceSimson Pharma compliance and trust
Trust signalCompliance7 records
Simson Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Simson Pharma leadership team
Management profileNumber of profiles
Profiles1 record
Simson Pharma subsidiaries and ownership
Company hierarchySubsidiaries3 records
Simson Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Simson Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Simson Pharma
What does Simson Pharma do?
Simson Pharma manufactures and supplies pharmaceutical reference materials used in drug quality control and analytical testing, including reference standards, working standards, impurity standards, stable isotope labelled compounds, drug metabolites, and research chemicals. The company operates custom synthesis services that produce complex organic molecules from milligram to kilogram scale, supported by in-house analytical testing and quality assurance laboratories located in Hyderabad, India.
Is Simson Pharma a public or private company?
Simson Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Simson Pharma founded?
Simson Pharma was founded in 2011. It employs 101 to 250 people.
Where is Simson Pharma based?
Simson Pharma is headquartered in Mumbai, India, in the Asia region.
How does Simson Pharma make money?
Five revenue lines are on record. Pharmaceutical Reference Standards are the primary driver. The others are impurity Standards, custom Synthesis Services, isotope Labelled Compounds and research Chemicals.
Who are Simson Pharma's main competitors?
Emerging players on record are Clearsynth, Selleck Chemicals and Cayman Chemical. Direct peers are LGC Standards, Toronto Research Chemicals (TRC), United States Pharmacopeia (USP), TCI Chemicals, Santa Cruz Biotechnology and Merck KGaA (Sigma-Aldrich). Thermo Fisher Scientific is listed as a broad incumbent.
Does Simson Pharma have an API?
No public API is recorded for Simson Pharma.